About Us

Home / About Us

KIMS Hospitals are one of the largest Corporate Health Care groups in A.P., and Telangana, in terms of number of patients treated and treatments offered and number of Clinical Trials conducted. KIMS Hospitals provide multi-disciplinary integrated healthcare services. There are 10 Multi-Specialty Hospitals under the “KIMS Hospitals Brand”. A comprehensive range of health care services across overn 25 Specialties and Super-specialties.

With the current strength of 60 Principal Investigators on its panel across all sites, and 20 certified and experienced Clinical Research Coordinators,; KIMS Clinical Research ensures ethical conduct of clinical research across the hospital group. KIMS Clinical Research conducts phase II, phase III and IV clinical trials, of which 50% are global multi-centric trials.

Over the years, KIMS Clinical Research has developed the capability of conducting clinical studies for drugs, devices, software applications and others. Further, we work with clients and partners with a variety of creative business models to enable progressive and quality research.

KIMS Clinical Research has established a benchmark in terms of ethics compliance and standards across its sites.

Both of our Institutional Ethics Committees are DCGI registered and DHR registered. Our EC is NABH accredited.

This gives an opportunity to conduct multi-centric -National and International Clinical trials, investigator initiated studies and academic projects, under Medical and Paramedical Courses along with PhD Projects. This includes other Institutions having tie-up with KIMS Clinical Research wing and Collaborative Study Groups or Cooperative Groups. An Investigator Initiated Study is a research effort in which the Physician initiates, designs and implements the study. KIMS Clinical Research is currently in discussions with pharmaceutical companies to enable Investigator Initiated Studies (IIS) by providing grants to clinicians. Many companies support the study with technical assistance, funding and drugs, if required.Such trials are more scientifically satisfying as the Investigator is probably trying to address some pertinent and current problem the answer to which has the potential to help a large number of patients and no financial/materialistic gains are possible.

The clinician driven research studies may get support from the pharma companies to enhance current technology/clinical practice. With the clinical expertise and experience, the KIMS Investigators have been conducting Investigator driven research studies in many therapeutic disciplines across several KIMS centers.

In KIMS Clinical Research effort to increase Clinician participation in Research, Investigator Initiated Study (LIS) Program was launched in KIMS Clinical Research about 10 years back. The IIS program aspires to enable achieving many add on values. KIMS Clinical Research acts not just as a site for the study, but also support them with structured framework to realize clinician ideas into funded research projects, data validation, statistical analysis, report writing, publications, visibility, etc. required for the study.

Ethics Committee for Clinical Trials (CT) under DCGI and
Bio Medical Research (BMR) under D H R

KIMS Hospitals are committed to bring health care of international standards within the reach of every individual. It undertakes bio-medical research and scientific experimentation on human subjects in the premises of the hospital to discover better medical and therapeutic modalities for the benefit of mankind. In order to see that due care and caution is taken at all stages of the research and to ensure that the research subject(s) and those affected by it are put to minimum risk from and by the research, the institution has constituted the Ethics Committees, which are independent bodies constituted and governed by the policies and procedures as per the regulatory requirements and SOPs of the Institution. The committee is reconstituted from time to time as per the standard operating procedures (SOP), and as per the regulatory guidelines.

The Ethics Committees of KIMS Hospitals are named as “KIMS Ethics Committee -(for Clinical Trials” (“IEC-CT”); and KIMS Institutional Ethics committee – Bio Medical & Health Research (“IEC-BHR”). The research activities of Institution shall be overseen by the IEC-CT and IEC-BMR. It is designed in accordance with Declaration of Helsinki and also the applicable guidelines formulated by Indian Council of Medical Research (ICMR), New Delhi and Central Drugs Standards Control Organization (CDSCO).

This committees shall evaluate, scrutinize and monitor all clinical research. The role of the Ethics Committees are “to protect and maintain the dignity, rights, safety and well-being of all research participants”.

It will provide independent, competent and timely review of the proposed research studies and approve before the initiation of the research projects. It ensures periodic review, evaluation and scrutinize and decide upon any ethical issue(s) relating to the research study.

The management of KIMS Hospitals supports the formation and activities of IEC-CT and IEC-BMR doing human research.

Grab your grant initiative was started by KIMS Clinical Research wing, and the idea behind inception of this initiative was to bridge the gap between doctors who have an idea for research and the funding available for them by different granting organization.

Research Studies/Projects

1. Total no of Clinical Trials 350
2. Total no of Ongoing Clinical Trials 30
3. Total no of International Clinical Trials 175
4. Total no of Academic studies 450
5. Total no of ongoing Academic studies 60
6. Total no of Principal Investigators 60
7. Total no of Research sites 20
8. Total no of Tie up Organizations/Colleges 16
9. Total no of Publication Reviewed 300
10. Total no of CRCs 40
11. Total no of Trainees 110
12. Total no of Events 18